United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
382.77
+5.97 (1.58%)
Nov 5, 2024, 4:00 PM EST - Market closed
United Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 17,089 | 10,333 | 12,674 | 9,731 | 6,746 | 3,865 | |
Market Cap Growth | 50.40% | -18.47% | 30.24% | 44.26% | 74.53% | -18.57% | |
Enterprise Value | 12,616 | 6,197 | 9,415 | 7,022 | 4,738 | 2,569 | |
Last Close Price | 376.80 | 219.89 | 278.09 | 216.08 | 151.79 | 88.08 | |
PE Ratio | 16.84 | 11.10 | 18.54 | 21.48 | 13.15 | -36.85 | |
PS Ratio | 6.25 | 4.44 | 6.55 | 5.77 | 4.55 | 2.67 | |
PB Ratio | 2.76 | 1.73 | 2.64 | 2.46 | 1.99 | 1.39 | |
P/FCF Ratio | 18.73 | 13.82 | 19.10 | 20.38 | 9.69 | -13.31 | |
P/OCF Ratio | 14.80 | 10.57 | 15.79 | 16.27 | 8.93 | -18.71 | |
EV/Sales Ratio | 4.58 | 2.66 | 4.86 | 4.17 | 3.19 | 1.77 | |
EV/EBITDA Ratio | 8.93 | 5.00 | 9.05 | 9.53 | 7.33 | -19.51 | |
EV/EBIT Ratio | 9.38 | 5.23 | 9.52 | 10.22 | 7.94 | -14.47 | |
EV/FCF Ratio | 14.05 | 8.29 | 14.19 | 14.71 | 6.80 | -8.85 | |
Debt / Equity Ratio | 0.07 | 0.12 | 0.17 | 0.20 | 0.24 | 0.31 | |
Debt / EBITDA Ratio | 0.28 | 0.59 | 0.77 | 1.09 | 1.24 | - | |
Debt / FCF Ratio | 0.45 | 0.98 | 1.21 | 1.68 | 1.15 | -2.93 | |
Asset Turnover | 0.39 | 0.35 | 0.35 | 0.34 | 0.35 | 0.40 | |
Inventory Turnover | 2.43 | 2.41 | 1.55 | 1.36 | 1.20 | 1.21 | |
Quick Ratio | 4.20 | 4.09 | 9.12 | 6.97 | 6.16 | 3.54 | |
Current Ratio | 4.58 | 4.41 | 9.85 | 7.61 | 6.70 | 4.03 | |
Return on Equity (ROE) | 18.81% | 18.27% | 16.61% | 12.94% | 16.67% | -3.75% | |
Return on Assets (ROA) | 11.89% | 11.22% | 11.02% | 8.78% | 8.74% | -3.04% | |
Return on Capital (ROIC) | 12.93% | 12.04% | 11.94% | 9.59% | 9.53% | -3.33% | |
Earnings Yield | 6.60% | 9.53% | 5.74% | 4.89% | 7.63% | -2.70% | |
FCF Yield | 5.34% | 7.23% | 5.24% | 4.91% | 10.32% | -7.51% | |
Buyback Yield / Dilution | 1.36% | -2.47% | -2.54% | -6.05% | -1.83% | 0.45% | |
Total Shareholder Return | 1.36% | -2.47% | -2.54% | -6.05% | -1.83% | 0.45% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.